Claudio Cerchione

Claudio Cerchione, MD, PhD, graduated in Medicine with honours from the Medical School at the University Federico II of Naples, Italy (July 2008), with a final thesis in Hematology.
During his Fellowship and PhD studies, Dr. Cerchione studied in detail Hematological malignancies, and his main research topics are Acute Leukemias and Multiple Myeloma.
He started his collaboration in the Hematology Department, AOU Federico II, Naples, Italy, in 2006, and there he completed with honours his Fellowship in July 2014 and his PhD program in May 2017.

Since 2018, he has worked in the Hematology Unit of Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, where he is Head of the Myeloma Research Group and Principal Investigator of many clinical trials company sponsored and non-company sponsored.

He has spent international research experiences in Friedrich-Wilhelms Universität, Bonn, Germany, in Universitade de Coimbra, Portugal, collaborating in their clinical and research projects, and in MD Anderson Cancer Center, Houston, USA, where he has been nominated International Ambassdor of SOHO (Society of Hematologic Oncology).

He is member of the editorial boards of many scientific journals, or Reviewer for several highly cited international journals and member of several international societies and President of Society of Hematologic Oncology Italy (SOHO Italy).

In 2018/2019 he was nominated by EHA (The European Hematology Association) as one of the winners of Clinical Research Training in Hematology.

He is author/co-author of many papers in peer-reviewed international journals.